AMYT
Amryt Pharma Plc
$14.7
Earnings Summary
Revenue | $61.13Mn |
Net Profits | $-20.8Mn |
Net Profit Margins | -34.02% |
Highlights
Amryt Pharma Plc’s revenue jumped 8.15% since last year same period to $61.13Mn in the Q3 2022. On a quarterly growth basis, Amryt Pharma Plc has generated -10.81% fall in its revenue since last 3-months.
Amryt Pharma Plc’s net profit fell -20.84% since last year same period to $-20.8Mn in the Q3 2022. On a quarterly growth basis, Amryt Pharma Plc has generated -195.01% fall in its net profits since last 3-months.
Amryt Pharma Plc’s net profit margin fell -11.73% since last year same period to -34.02% in the Q3 2022. On a quarterly growth basis, Amryt Pharma Plc has generated -230.77% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Amryt Pharma Plc post its latest quarter earnings
EPS Estimate Current Quarter | -0.01 |
EPS Estimate Current Year | -0.01 |
Highlights
Amryt Pharma Plc’s earning per share (EPS) estimates for the current quarter stand at -0.01 - a 72.08% jump from last quarter’s estimates.
Amryt Pharma Plc’s earning per share (EPS) estimates for the current year stand at -0.01.
Key Ratios
Key ratios of the Amryt Pharma Plc post its Q2 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Amryt Pharma Plc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the Amryt Pharma Plc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-04 | -0.01 | 0 | 100% |
2023-04-19 | -0.02 | 0 | 100% |
₹0 US Stocks a/c Opening Fee